Reset filters
25 February 2021

Keynote lecture session 2021

  • Health and wearables: Is this the dawn of a new age for cardiovascular medicine? Martin Cowie
  • Professor Sheila Glennis Haworth Memorial Lecture - Translational Research on PAH, Jason Yuan 
  • Biomarker Analysis of the PULSAR Study: An Ongoing Phase 2, Double-Blind, Placebo-Controlled, Randomized Study to Compare the Efficacy and Safety of Sotatercept (ACE-011) Versus Placebo When Added to Standard of Care for the Treatment of PAH, Marc Humbert
  • Switching from PDE5i to riociguat in patients with PAH: The REPLACE study, Raymond Benza
  • A diagnostic miRNA signature for PAH using a consensus machine learning approach (Rupert Swift Award 2021), Niamh Errington
PVRI Digital Webinar Series
11 February 2021

Around the globe: the global burden of pulmonary hypertension

  • The view of the World Heart Federation (WHF), Fausto Pinto
  • Update on the Global Burden of PH Project of the Institute for Health Metrics and Evaluation (IHME), Sophia Emmons-Bell
  • PVRI GoDeep: Perspectives of a global meta-registry, Werner Seeger
  • Mortality of idiopathic/hereditary and connective tissue disease-associated pulmonary arterial hypertension: the data from first single center prospective registry in Indonesia, Anggoro Budi Hartopo
  • Triple therapy in pulmonary arterial hypertension in an expert centre in Mexico City. Real-life results, Humberto Garcia-Aguilar
PVRI Digital Webinar Series